A Randomized Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus
A Randomized Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus
About this item
Full title
Author / Creator
Revello, Maria Grazia , Lazzarotto, Tiziana , Guerra, Brunella , Spinillo, Arsenio , Ferrazzi, Enrico , Kustermann, Alessandra , Guaschino, Secondo , Vergani, Patrizia , Todros, Tullia , Frusca, Tiziana , Arossa, Alessia , Furione, Milena , Rognoni, Vanina , Rizzo, Nicola , Gabrielli, Liliana , Klersy, Catherine , Gerna, Giuseppe and CHIP Study Group
Publisher
Waltham, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Waltham, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Congenital infection with cytomegalovirus is a major cause of morbidity in neonates. In this phase 2, placebo-controlled trial, hyperimmune globulin given to mothers with primary CMV infection at 5 to 26 weeks of gestation did not significantly alter the course of infection.
Every year, approximately 0.6% of all newborns in the United States and...
Alternative Titles
Full title
A Randomized Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus
Authors, Artists and Contributors
Author / Creator
Lazzarotto, Tiziana
Guerra, Brunella
Spinillo, Arsenio
Ferrazzi, Enrico
Kustermann, Alessandra
Guaschino, Secondo
Vergani, Patrizia
Todros, Tullia
Frusca, Tiziana
Arossa, Alessia
Furione, Milena
Rognoni, Vanina
Rizzo, Nicola
Gabrielli, Liliana
Klersy, Catherine
Gerna, Giuseppe
CHIP Study Group
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1513048750
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1513048750
Other Identifiers
ISSN
0028-4793,1533-4406
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1310214
